The DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.
Mesenchymal Stem Cell-Based Immunomodulation: Properties and Clinical Application
Open accessAbstract
Mesenchymal stem cells (MSCs) are multipotent stem cells characterized by self-renewal, production of clonal cell populations, and multilineage differentiation. They exist in nearly all tissues and play a significant role in tissue repair and regeneration. Additionally, MSCs possess wide immunoregulatory properties via interaction with immune cells in both innate and adaptive immune systems, leading to immunosuppression of various effector functions. Numerous bioactive molecules secreted by MSCs, particularly cytokines, growth factors, and chemokines, exert autocrine/paracrine effects that modulate the physiological processes of MSCs. These invaluable virtues of MSCs provide new insight into potential treatments for tissue damage and inflammation. In particular, their extensive immunosuppressive properties are being explored for promising therapeutic application in immune disorders. Recently, clinical trials for MSC-mediated therapies have rapidly developed for immune-related diseases following reports from preclinical studies declaring their therapeutic safety and efficacy. Though immunotherapy of MSCs remains controversial, these clinical trials pave the way for their widespread therapeutic application in immune-based diseases. In this review, we will summarize and update the latest research findings and clinical trials on MSC-based immunomodulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Exploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144 · cited 1×
“Generally, M1 macrophages possess prominent antimicrobial properties by releasing a variety of chemokines and inflammatory cytokines, whereas M2 macrophages are able to alleviate inflammation and expedite tissue repair via secretion of IL-10 and trophic factors [53].”
BackgroundCaplan, A. I. (1991) · Journal of Orthopaedic Research · doi:10.1002/jor.1100090504 · Cited by 6,548
Vos, T., Barber, R. M., Bell, B., Bertozzi-Villa, A., Biryukov, S., Bolliger, I., Charlson, F., Davis, A., Degenhardt, L., Dicker, D., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60692-4 · Cited by 6,414
Human mesenchymal stem cells modulate allogeneic immune cell responses
Aggarwal, S., & Pittenger, M. F. (2005) · Blood · doi:10.1182/blood-2004-04-1559 · Cited by 4,511
Macrophages in Tissue Repair, Regeneration, and Fibrosis
Wynn, T. A., & Vannella, K. M. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.015 · Cited by 4,481
(2016) · Diagnostic Imaging: Brain · doi:10.1016/b978-0-323-37754-6.50094-4 · Cited by 3,990
Mesenchymal stem cells in health and disease
Uccelli, A., Moretta, L., & Pistoia, V. (2008) · Nature Reviews Immunology · doi:10.1038/nri2395 · Cited by 3,746
Di Nicola, M., Carlo-Stella, C., Magni, M., Milanesi, M., Longoni, P. D., Matteucci, P., Grisanti, S., & Gianni, A. M. (2002) · Blood · doi:10.1182/blood.v99.10.3838 · Cited by 3,226
Tsokos, G. C. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1100359 · Cited by 2,736
Le Blanc, K., Rasmusson, I., Sundberg, B., Götherström, C., Hassan, M., Uzunel, M., & Ringdén, O. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16104-7 · Cited by 2,734
Le Blanc, K., Frassoni, F., Ball, L., Locatelli, F., Roelofs, H., Lewis, I., Lanino, E., Sundberg, B., Bernardo, M. E., Remberger, M., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60690-x · Cited by 2,695
Németh, K., Leelahavanichkul, A., Yuen, P. S. T., Mayer, B., Parmelee, A., Doi, K., Robey, P. G., Leelahavanichkul, K., Koller, B. H., Brown, J. M., et al. (2009) · Nature Medicine · doi:10.1038/nm.1905 · Cited by 2,364 · cited 13×
“In vitro, PGE2 produced by mouse MSCs restrain several cell functions, such as TNF generation and migration [97].”
BackgroundInfluentialNasir, O. (2013) · Kidney and Blood Pressure Research · doi:10.1159/000350152 · Cited by 2,331
Bartholomew, A., Sturgeon, C., Siatskas, M., Ferrer, K., McIntosh, K., Patil, S., Hardy, W., Devine, S., Ucker, D., Deans, R., et al. (2002) · Experimental Hematology · doi:10.1016/s0301-472x(01)00769-x · Cited by 2,295
Ren, G., Zhang, L., Zhao, X., Xu, G., Zhang, Y., Roberts, A. I., Zhao, R. C., & Shi, Y. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2007.11.014 · Cited by 2,101
Global Prevalence of Diabetes: Estimates for the Year 2000 and Projections for 2030
Rathmann, W., & Giani, G. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2568 · Cited by 1,994
Lee, R. H., Pulin, A. A., Seo, M. J., Kota, D. J., Ylostalo, J., Larson, B. L., Semprun-Prieto, L., Delafontaine, P., & Prockop, D. J. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.05.003 · Cited by 1,898
Immunomodulatory properties of mesenchymal stromal cells
Nauta, A. J., & Fibbe, W. E. (2007) · Blood · doi:10.1182/blood-2007-02-069716 · Cited by 1,788
Hass, R., Kasper, C., Böhm, S., & Jacobs, R. (2011) · Cell Communication and Signaling · doi:10.1186/1478-811x-9-12 · Cited by 1,748
Transcriptional control of effector and memory CD8+ T cell differentiation
Kaech, S. M., & Cui, W. (2012) · Nature Reviews Immunology · doi:10.1038/nri3307 · Cited by 1,628
Cytokines Induce the Development of Functionally Heterogeneous T Helper Cell Subsets
O'Garra, A. (1998) · Immunity · doi:10.1016/s1074-7613(00)80533-6 · Cited by 1,533
Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications
Wang, Y., Chen, X., Cao, W., & Shi, Y. (2014) · Nature Immunology · doi:10.1038/ni.3002 · Cited by 1,452
Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy
Zappia, E., Casazza, S., Pedemonte, E., Benvenuto, F., Bonanni, I., Gerdoni, E., Giunti, D., Ceravolo, A., Cazzanti, F., Frassoni, F., et al. (2005) · Blood · doi:10.1182/blood-2005-04-1496 · Cited by 1,430
Mesenchymal Stromal Cells: Sensors and Switchers of Inflammation
Bernardo, M. E., & Fibbe, W. E. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2013.09.006 · Cited by 1,383
Jiang, X.-X., Zhang, Y., Liu, B., Zhang, S.-X., Wu, Y., Yu, X.-D., & Mao, N. (2005) · Blood · doi:10.1182/blood-2004-02-0586 · Cited by 1,346
Role for Interferon-γ in the Immunomodulatory Activity of Human Bone Marrow Mesenchymal Stem Cells
Krampera, M., Cosmi, L., Angeli, R., Pasini, A., Liotta, F., Andreini, A., Santarlasci, V., Mazzinghi, B., Pizzolo, G., Vinante, F., et al. (2006) · Stem Cells · doi:10.1634/stemcells.2005-0008 · Cited by 1,311
Liechty, K. W., MacKenzie, T. C., Shaaban, A. F., Radu, A., Moseley, A. B., Deans, R., Marshak, D. R., & Flake, A. W. (2000) · Nature Medicine · doi:10.1038/81395 · Cited by 1,215
Hare, J. M., Fishman, J. E., Gerstenblith, G., DiFede Velazquez, D. L., Zambrano, J. P., Suncion, V. Y., Tracy, M., Ghersin, E., Johnston, P. V., Brinker, J. A., et al. (2012) · JAMA · doi:10.1001/jama.2012.25321 · Cited by 1,192
Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals
Djouad, F., Plence, P., Bony, C., Tropel, P., Apparailly, F., Sany, J., Noël, D., & Jorgensen, C. (2003) · Blood · doi:10.1182/blood-2003-04-1193 · Cited by 1,166
Spaggiari, G. M., Capobianco, A., Abdelrazik, H., Becchetti, F., Mingari, M. C., & Moretta, L. (2008) · Blood · doi:10.1182/blood-2007-02-074997 · Cited by 1,146
Incidence and trends of childhood type 1 diabetes worldwide 1990–1999
The DIAMOND Project Group (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01925.x · Cited by 1,085
Dynamics of B cells in germinal centres
De Silva, N. S., & Klein, U. (2015) · Nature Reviews Immunology · doi:10.1038/nri3804 · Cited by 1,084
Multipotent mesenchymal stromal cells and the innate immune system
Le Blanc, K., & Mougiakakos, D. (2012) · Nature Reviews Immunology · doi:10.1038/nri3209 · Cited by 1,018
Interactions Between Human Mesenchymal Stem Cells and Natural Killer Cells
Sotiropoulou, P. A., Perez, S. A., Gritzapis, A. D., Baxevanis, C. N., & Papamichail, M. (2006) · Stem Cells · doi:10.1634/stemcells.2004-0359 · Cited by 956 · cited 2×
“MSCs inhibit the effects of NK cells with immunosuppressive secretors, such as PGE2, TGF-β, and sHLA-G, leading to induction of cytotoxic effects against virus-infected cells and reduction of IFN-γ secretion [46].”
BackgroundNitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells
Sato, K., Ozaki, K., Oh, I., Meguro, A., Hatanaka, K., Nagai, T., Muroi, K., & Ozawa, K. (2007) · Blood · doi:10.1182/blood-2006-02-002246 · Cited by 954
Mesenchymal stromal cells: new directions
Keating, A. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.05.015 · Cited by 778
Mesenchymal-Stem-Cell-Induced Immunoregulation Involves FAS-Ligand-/FAS-Mediated T Cell Apoptosis
Akiyama, K., Chen, C., Wang, D., Xu, X., Qu, C., Yamaza, T., Cai, T., Chen, W., Sun, L., & Shi, S. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.03.007 · Cited by 705
Natural killer cells and dendritic cells: rendezvous in abused tissues
Moretta, A. (2002) · Nature Reviews Immunology · doi:10.1038/nri956 · Cited by 704
Augello, A., Tasso, R., Negrini, S. M., Amateis, A., Indiveri, F., Cancedda, R., & Pennesi, G. (2005) · European Journal of Immunology · doi:10.1002/eji.200425405 · Cited by 696
Ren, G., Zhao, X., Zhang, L., Zhang, J., L'Huillier, A., Ling, W., Roberts, A. I., Le, A. D., Shi, S., Shao, C., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902023 · Cited by 656
How mesenchymal stem cells interact with tissue immune responses
Shi, Y., Su, J., Roberts, A. I., Shou, P., Rabson, A. B., & Ren, G. (2012) · Trends in Immunology · doi:10.1016/j.it.2011.11.004 · Cited by 633
Zhang, Q.-Z., Su, W.-R., Shi, S.-H., Wilder-Smith, P., Xiang, A. P., Wong, A., Nguyen, A. L., Kwon, C. W., & Le, A. D. (2010) · Stem Cells · doi:10.1002/stem.503 · Cited by 620
Mesenchymal stem cell therapy: Two steps forward, one step back
Ankrum, J., & Karp, J. M. (2010) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2010.02.005 · Cited by 614
Species Variation in the Mechanisms of Mesenchymal Stem Cell-Mediated Immunosuppression
Ren, G., Su, J., Zhang, L., Zhao, X., Ling, W., L'huillie, A., Zhang, J., Lu, Y., Roberts, A. I., Ji, W., et al. (2009) · Stem Cells · doi:10.1002/stem.118 · Cited by 597
Voltarelli, J. C., Couri, C. E. B., Stracieri, A. B. P. L., Oliveira, M. C., Moraes, D. A., Pieroni, F., Coutinho, M., Malmegrim, K. C. R., Foss-Freitas, M. C., Simões, B. P., et al. (2007) · JAMA · doi:10.1001/jama.297.14.1568 · Cited by 573
Ciccocioppo, R., Bernardo, M. E., Sgarella, A., Maccario, R., Avanzini, M. A., Ubezio, C., Minelli, A., Alvisi, C., Vanoli, A., Calliada, F., et al. (2011) · Gut · doi:10.1136/gut.2010.214841 · Cited by 558
Bai, L., Lennon, D. P., Eaton, V., Maier, K., Caplan, A. I., Miller, S. D., & Miller, R. H. (2009) · Glia · doi:10.1002/glia.20841 · Cited by 546
Molecular control of activation and priming in macrophages
Glass, C. K., & Natoli, G. (2016) · Nature Immunology · doi:10.1038/ni.3306 · Cited by 530
Shi, C., Jia, T., Mendez-Ferrer, S., Hohl, T. M., Serbina, N. V., Lipuma, L., Leiner, I., Li, M. O., Frenette, P. S., & Pamer, E. G. (2011) · Immunity · doi:10.1016/j.immuni.2011.02.016 · Cited by 506
Contextual Regulation of Inflammation: A Duet by Transforming Growth Factor-β and Interleukin-10
Li, M. O., & Flavell, R. A. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.003 · Cited by 501
Frenette, P. S., Pinho, S., Lucas, D., & Scheiermann, C. (2013) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095919 · Cited by 462 · cited 2×
“In fact, a variety of immune disorder diseases, including multiple sclerosis, Crohn’s disease, GVHD, SLEs, and type 1 diabetes, have entered clinical trials for treatment with MSCs [80].”
BackgroundMSCs: Delivery Routes and Engraftment, Cell-Targeting Strategies, and Immune Modulation
Kean, T. J., Lin, P., Caplan, A. I., & Dennis, J. E. (2013) · Stem Cells International · doi:10.1155/2013/732742 · Cited by 433
Bai, L., Lennon, D. P., Caplan, A. I., DeChant, A., Hecker, J., Kranso, J., Zaremba, A., & Miller, R. H. (2012) · Nature Neuroscience · doi:10.1038/nn.3109 · Cited by 421
Rafei, M., Campeau, P. M., Aguilar-Mahecha, A., Buchanan, M., Williams, P., Birman, E., Yuan, S., Young, Y. K., Boivin, M.-N., Forner, K., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803962 · Cited by 381
The immunomodulatory capacity of mesenchymal stem cells
Gebler, A., Zabel, O., & Seliger, B. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.10.004 · Cited by 365
Ge, W., Jiang, J., Arp, J., Liu, W., Garcia, B., & Wang, H. (2010) · Transplantation · doi:10.1097/tp.0b013e3181fed001 · Cited by 352
Lukacs-Kornek, V., Malhotra, D., Fletcher, A. L., Acton, S. E., Elpek, K. G., Tayalia, P., Collier, A.-R., & Turley, S. J. (2011) · Nature Immunology · doi:10.1038/ni.2112 · Cited by 312
Yamane, H., & Paul, W. E. (2013) · Immunological Reviews · doi:10.1111/imr.12032 · Cited by 304
Mesenchymal Stromal Cells: A Novel Treatment Modality for Tissue Repair
Bernardo, M. E., Locatelli, F., & Fibbe, W. E. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04607.x · Cited by 295
Mesenchymal Stem Cells Cooperate with Bone Marrow Cells in Therapy of Diabetes
Urbán, V. S., Kiss, J., Kovács, J., Gócza, E., Vas, V., Monostori, Ė., & Uher, F. (2008) · Stem Cells · doi:10.1634/stemcells.2007-0267 · Cited by 292
Freitag, J., Bates, D., Boyd, R., Shah, K., Barnard, A., Huguenin, L., & Tenen, A. (2016) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-016-1085-9 · Cited by 281
Mesenchymal stem cells impair in vivo T-cell priming by dendritic cells
Chiesa, S., Morbelli, S., Morando, S., Massollo, M., Marini, C., Bertoni, A., Frassoni, F., Bartolomé, S. T., Sambuceti, G., Traggiai, E., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103650108 · Cited by 269
Wang, D., Zhang, H., Liang, J., Li, X., Feng, X., Wang, H., Hua, B., Liu, B., Lu, L., Gilkeson, G. S., et al. (2013) · Cell Transplantation · doi:10.3727/096368911x582769c · Cited by 268
Immunologic properties of human fetal mesenchymal stem cells
Götherström, C., Ringdén, O., Tammik, C., Zetterberg, E., Westgren, M., & Le Blanc, K. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2003.07.022 · Cited by 245
Soluble mediators from mesenchymal stem cells suppress T cell proliferation by inducing IL-10
Yang, S.-H., Park, M.-J., Yoon, I.-H., Kim, S.-Y., Hong, S.-H., Shin, J.-Y., Nam, H.-Y., Kim, Y.-H., Kim, B., & Park, C.-G. (2009) · Experimental and Molecular Medicine · doi:10.3858/emm.2009.41.5.035 · Cited by 241
Su, J., Chen, X., Huang, Y., Li, W., Li, J., Cao, K., Cao, G., Zhang, L., Li, F., Roberts, A. I., et al. (2014) · Cell Death & Differentiation · doi:10.1038/cdd.2013.149 · Cited by 238
Prockop, D. J. (2013) · Stem Cells · doi:10.1002/stem.1400 · Cited by 230
Chaturvedi, P., Gilkes, D. M., Takano, N., & Semenza, G. L. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406655111 · Cited by 226
Soroosh, P., & Doherty, T. A. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03114.x · Cited by 226
Amino acid sequence of the encephalitogenic basic protein from human myelin
Carnegie, P. R. (1971) · Biochemical Journal · doi:10.1042/bj1230057 · Cited by 219
Anzalone, R., Iacono, M. L., Corrao, S., Magno, F., Loria, T., Cappello, F., Zummo, G., Farina, F., & La Rocca, G. (2010) · Stem Cells and Development · doi:10.1089/scd.2009.0299 · Cited by 215
Rose, R. A., Jiang, H., Wang, X., Helke, S., Tsoporis, J. N., Gong, N., Keating, S. C. J., Parker, T. G., Backx, P. H., & Keating, A. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0329 · Cited by 207
Jarvinen, L., Badri, L., Wettlaufer, S., Ohtsuka, T., Standiford, T. J., Toews, G. B., Pinsky, D. J., Peters-Golden, M., & Lama, V. N. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.6.4389 · Cited by 206
T‐cell metabolism governing activation, proliferation and differentiation; a modular view
Dimeloe, S., Burgener, A., Grählert, J., & Hess, C. (2017) · Immunology · doi:10.1111/imm.12655 · Cited by 201
TSG-6: An IL-1 /TNF-inducible protein with anti-inflammatory activity
Wisniewski, H.-G., & Vilĉek, J. (1997) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(97)00008-7 · Cited by 200
Yañez, R., Oviedo, A., Aldea, M., Bueren, J. A., & Lamana, M. L. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.08.008 · Cited by 177
Preconditioning of Human Mesenchymal Stem Cells to Enhance Their Regulation of the Immune Response
Saparov, A., Ogay, V., Nurgozhin, T., Jumabay, M., & Chen, W. C. W. (2016) · Stem Cells International · doi:10.1155/2016/3924858 · Cited by 170
Selleri, S., Bifsha, P., Civini, S., Pacelli, C., Dieng, M. M., Lemieux, W., Jin, P., Bazin, R., Patey, N., Marincola, F. M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8623 · Cited by 167
Chinnadurai, R., Copland, I. B., Garcia, M. A., Petersen, C. T., Lewis, C. N., Waller, E. K., Kirk, A. D., & Galipeau, J. (2016) · Stem Cells · doi:10.1002/stem.2415 · Cited by 167
Favaro, E., Carpanetto, A., Caorsi, C., Giovarelli, M., Angelini, C., Cavallo-Perin, P., Tetta, C., Camussi, G., & Zanone, M. M. (2016) · Diabetologia · doi:10.1007/s00125-015-3808-0 · Cited by 163
Molecular Characterization of Spontaneous Mesenchymal Stem Cell Transformation
Rubio, D., Garcia, S., Paz, M. F., De la Cueva, T., Lopez-Fernandez, L. A., Lloyd, A. C., Garcia-Castro, J., & Bernad, A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001398 · Cited by 161
Rashedi, I., Gómez-Aristizábal, A., Wang, X., Viswanathan, S., & Keating, A. (2016) · Stem Cells · doi:10.1002/stem.2485 · Cited by 144
Mesenchymal Stem Cell Therapy for Autoimmune Disease: Risks and Rewards
Munir, H., & McGettrick, H. M. (2015) · Stem Cells and Development · doi:10.1089/scd.2015.0008 · Cited by 142
Renner, P., Eggenhofer, E., Rosenauer, A., Popp, F., Steinmann, J., Slowik, P., Geissler, E. K., Piso, P., Schlitt, H. J., & Dahlke, M. H. (2009) · Transplantation Proceedings · doi:10.1016/j.transproceed.2009.06.119 · Cited by 141
Li, H., Guo, Z., Jiang, X., Zhu, H., Li, X., & Mao, N. (2008) · Stem Cells · doi:10.1634/stemcells.2008-0146 · Cited by 140
Elabd, C., Centeno, C. J., Schultz, J. R., Lutz, G. E., Ichim, T. E., & Silva, F. J. (2016) · Journal of Translational Medicine · doi:10.1186/s12967-016-1015-5 · Cited by 133
Choi, E. W., Shin, I. S., Park, S., Park, J. H., Kim, J. S., Yoon, E. J., Kang, S. K., Ra, J. C., & Hong, S. H. (2011) · Arthritis & Rheumatism · doi:10.1002/art.33313 · Cited by 132
Gao, W., Sun, Y., Shi, J., Li, C., Fang, S., Wang, D., Deng, X.-Q., Wen, W., & Fu, Q. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0499-0 · Cited by 131
Qian, H. (1998) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000026 · Cited by 130
Interaction between Mesenchymal Stem Cells and B-Cells
Fan, L., Hu, C., Chen, J., Cen, P., Wang, J., & Li, L. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050650 · Cited by 130
Cho, K., Ju, S., Cho, S. J., Jung, Y., Woo, S., Seoh, J., Han, H., & Ryu, K. (2009) · Cell Biology International · doi:10.1016/j.cellbi.2009.04.023 · Cited by 129
Connick, P., Kolappan, M., Patani, R., Scott, M. A., Crawley, C. R., He, X., Richardson, K., Barber, K., Webber, D. J., Wheeler‐Kingshott, C. A. M. G., et al. (2011) · Trials · doi:10.1186/1745-6215-12-62 · Cited by 127
Bone marrow stromal cells inhibit mast cell function via a COX2‐dependent mechanism
Brown, J. M., Németh, K., Kushnir‐Sukhov, N. M., Metcalfe, D. D., & Mezey, É. (2011) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2010.03685.x · Cited by 126
The interaction between mesenchymal stem cells and steroids during inflammation
Chen, X., Gan, Y., Li, W., Su, J., Zhang, Y., Huang, Y., Roberts, A. I., Han, Y., Li, J., Wang, Y., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2013.537 · Cited by 120
Potential of mesenchymal stem cell therapy
Dazzi, F., & Horwood, N. J. (2007) · Current Opinion in Oncology · doi:10.1097/cco.0b013e3282f0e116 · Cited by 118
Immune regulatory properties of multipotent mesenchymal stromal cells: Where do we stand?
Bassi, Ê. J., Aita, C. A. M., & CAMARA, N. O. S. (2011) · World Journal of Stem Cells · doi:10.4252/wjsc.v3.i1.1 · Cited by 113
Role of mesenchymal stem cell therapy in Crohn’s disease
Dalal, J. D., Gandy, K. L., & Domen, J. (2012) · Pediatric Research · doi:10.1038/pr.2011.56 · Cited by 112
Barrachina, L., Remacha, A. R., Romero, A., Vázquez, F. J., Albareda, J., Prades, M., Gosálvez, J., Roy, R., Zaragoza, P., Martín‐Burriel, I., et al. (2016) · Stem Cells and Development · doi:10.1089/scd.2016.0209 · Cited by 108
Imprinting the Fate of Antigen-Reactive B Cells through the Affinity of the B Cell Receptor
O’Connor, B. P., Vogel, L. A., Zhang, W., Loo, W. M., Shnider, D., Lind, E. F., Ratliff, M., Noelle, R. J., & Erickson, L. D. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.7723 · Cited by 104
Characterization of Nestin, a Selective Marker for Bone Marrow Derived Mesenchymal Stem Cells
Xie, L., Zeng, X. Y., Hu, J., & Chen, Q. (2015) · Stem Cells International · doi:10.1155/2015/762098 · Cited by 103
Self-citationMesenchymal Stromal Cells and Viral Infection
Thanunchai, M., Hongeng, S., & Thitithanyanont, A. (2015) · Stem Cells International · doi:10.1155/2015/860950 · Cited by 93
Mesenchymal stem cells and their therapeutic applications in inflammatory bowel disease
Mao, F., Tu, Q., Wang, L., Chu, F., Li, X., Li, H. S., & Xu, W. (2017) · Oncotarget · doi:10.18632/oncotarget.16682 · Cited by 89
Fetal and adult multipotent mesenchymal stromal cells are killed by different pathways
Gotherstrom, C. O. T., Lundqvist, A., Duprez, I. R., Childs, R. W., Berg, L., & Blanc, K. L. (2010) · Cytotherapy · doi:10.3109/14653249.2010.523077 · Cited by 86
Weil, B. R., Manukyan, M. C., Herrmann, J. L., Wang, Y., Abarbanell, A. M., Poynter, J. A., & Meldrum, D. R. (2010) · Surgery · doi:10.1016/j.surg.2010.03.010 · Cited by 82
Cui, R., Rekasi, H., Hepner-Schefczyk, M., Fessmann, K., Petri, R. M., Bruderek, K., Brandau, S., Jäger, M., & Flohé, S. B. (2016) · Stem Cell Research & Therapy · doi:10.1186/s13287-016-0353-9 · Cited by 78
Abomaray, F., Jumah, M. A., Alsaad, K. O., Jawdat, D. M., Al-Khaldi, A., Alaskar, A. S., Harthy, S. A., Subayyil, A. M. A., Khatlani, T., Alawad, A. O., et al. (2016) · Stem Cells International · doi:10.1155/2016/5184601 · Cited by 77
Lotfinia, M., Kadivar, M., Piryaei, A., Pournasr, B., Sardari, S., Sodeifi, N., Sayahpour, F., & Baharvand, H. (2016) · Stem Cells and Development · doi:10.1089/scd.2016.0244 · Cited by 75
Mesenchymal stem cell-based therapy for type 1 diabetes.
Wu, H., & Mahato, R. I. (2014) · PubMed · Cited by 73
Bone Marrow GvHD after Allogeneic Hematopoietic Stem Cell Transplantation
Szyska, M., & Na, I. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00118 · Cited by 71
The life of regulatory T cells
Gratz, I. K., Rosenblum, M. D., & Abbas, A. K. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12011 · Cited by 68
Consentius, C., Akyüz, L., Schmidt-Lucke, J. A., Tschöpe, C., Pinzur, L., Ofir, R., Reinke, P., Volk, H., & Juelke, K. (2015) · Stem Cells · doi:10.1002/stem.2104 · Cited by 64
Steven, J. G. (2004) · Frontiers in bioscience · doi:10.2741/1373 · Cited by 60
Mesenchymal Stem Cells Recruit Macrophages to Alleviate Experimental Colitis Through TGFβ1
Liu, W., Zhang, S., Gu, S., Sang, L.-X., & Dai, C. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000369743 · Cited by 59
Depoil, D., Weber, M., Treanor, B., Fleire, S. J., Carrasco, Y. R., Harwood, N. E., & Batista, F. D. (2009) · Science Signaling · doi:10.1126/scisignal.263pt1 · Cited by 58
Mesenchymal Stem Cells Prime Proliferating Adult Neural Progenitors Toward an Oligodendrocyte Fate
Steffenhagen, C., Dechant, F.-X., Priglinger, E., Furtner, T., Weidner, N., Küry, P., Aigner, L., & Rivera, F. J. (2011) · Stem Cells and Development · doi:10.1089/scd.2011.0137 · Cited by 58
Clinical Applications for Biomarkers of Acute and Chronic Graft-versus-Host Disease
Levine, J. E., Paczesny, S., & Sarantopoulos, S. (2012) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2011.10.019 · Cited by 55
Sharma, J., Hampton, J. M., Valiente, G. R., Wada, T. T., Steigelman, H., Young, M. C., Spurbeck, R. R., Blazek, A. D., Bösch, S., Jarjour, W. N., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00526 · Cited by 54
AFF1 and AFF4 differentially regulate the osteogenic differentiation of human MSCs
Zhou, C., Xiong, Q., Zhu, X., Du, W., Deng, P., Li, X., Jiang, Y., Zou, S., Wang, C., & Yuan, Q. (2017) · Bone Research · doi:10.1038/boneres.2017.44 · Cited by 51
Self-citationXu, L.-L., Fu, H., Zhang, J., Feng, F., Wang, Q., Zhu, X., Xue, J., Wang, C., Chen, Q., Liu, X., et al. (2017) · Stem Cells and Development · doi:10.1089/scd.2017.0078 · Cited by 51
Aboalola, D. A., & Han, V. K. M. (2017) · Stem Cells International · doi:10.1155/2017/8286248 · Cited by 48
Tang, K. C., Trzaska, K. A., Sv, S., Kotenko, S. V., Schwander, S., Ellner, J. J., & Rameshwar, P. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.3.1826 · Cited by 47
Hematopoietic cell transplantation for Crohn’s disease; is it time?
Leung, Y. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i41.6665 · Cited by 41
Aikawa, E., Fujita, R., Asai, M., Kaneda, Y., & Tamai, K. (2016) · Stem Cells and Development · doi:10.1089/scd.2016.0067 · Cited by 40
Rengasamy, M., Gupta, P. K., Kolkundkar, U., Singh, G., Balasubramanian, S., SundarRaj, S., Chullikana, A., & Majumdar, A. S. (2016) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_1842_15 · Cited by 40
Feng, X., Che, N., Liu, Y., Chen, H., Wang, D., Li, X., Chen, W., Ma, X., Hua, B., Gao, X., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38879 · Cited by 37
Wolf, D., Reinhard, A., Wolf, D., et al. (2008) · Scandinavian Cardiovascular Journal · doi:10.1080/14017430802100280 · Cited by 36
Added effects of dexamethasone and mesenchymal stem cells on early Natural Killer cell activation
Michelo, C. M., Fasse, E., van Cranenbroek, B., Linda, K., van der Meer, A., Abdelrazik, H., & Joosten, I. (2016) · Transplant Immunology · doi:10.1016/j.trim.2016.04.008 · Cited by 34
Huang, Y., Chen, P., Zhang, C. B., Ko, G. J., Ruiz, M., Fiorina, P., Hussain, M. A., Wasowska, B. A., Rabb, H., & Womer, K. L. (2010) · Transplantation · doi:10.1097/tp.0b013e3181fdd9eb · Cited by 32
Qu, M., Xu, Y., Liu, D., Ma, Y., Zhu, J., Cui, J., Yu, M., Li, C., & Guo, D. (2017) · Stem Cells and Development · doi:10.1089/scd.2016.0348 · Cited by 32
Korea okays stem cell therapies despite limited peer-reviewed data
Wohn, D. Y. (2012) · Nature Medicine · doi:10.1038/nm0312-329a · Cited by 31
Advances in mesenchymal stromal cell therapy in the management of Crohn’s disease
Ibraheim, H., Giacomini, C., Kassam, Z., Dazzi, F., & Powell, N. (2017) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2018.1393332 · Cited by 28
Park, M., Kim, Y., Ryu, J.-H., Woo, S., & Ryu, K. (2015) · Stem Cells International · doi:10.1155/2015/106540 · Cited by 26
Tuettenberg, A., Becker, C., Correll, A., Steinbrink, K., & Jonuleit, H. (2011) · PubMed · Cited by 19
Rebeiro, P. F., & Moore, J. J. (2015) · Internal Medicine Journal · doi:10.1111/imj.12944 · Cited by 17
Immunomodulatory effects of foreskin mesenchymal stromal cells on natural killer cells
Najar, M., Fayyad‐Kazan, M., Meuleman, N., Bron, D., Fayyad‐Kazan, H., & Lagneaux, L. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26305 · Cited by 16
Li, F., & Zhao, S. (2016) · Stem Cells International · doi:10.1155/2016/7961816 · Cited by 15
Wu, Y., Zhang, S., & Yuan, Q. (2016) · Stem Cells and Development · doi:10.1089/scd.2016.0062 · Cited by 14
Self-citation
Cited by
Recent Updates of Diagnosis, Pathophysiology, and Treatment on Osteoarthritis of the Knee
Jang, S., Lee, K., & Ju, J. H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052619 · Cited by 803
Exosomes Derived from Bone Marrow Mesenchymal Stem Cells as Treatment for Severe COVID-19
Sengupta, V., Sengupta, S., Lazo, A., Woods, P., Nolan, A., & Bremer, N. (2020) · Stem Cells and Development · doi:10.1089/scd.2020.0080 · Cited by 748
Mesenchymal stem cells: Cell therapy and regeneration potential
Brown, C., McKee, C., Bakshi, S., Walker, K., Hakman, E., Halassy, S., Svinarich, D., Dodds, R., Govind, C. K., & Chaudhry, G. R. (2019) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.2914 · Cited by 609
Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance
Khalaf, K., Hana, D., Chou, J. T.-T., Singh, C., Mackiewicz, A., & Kaczmarek, M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.656364 · Cited by 513
Giorgino, R., Albano, D., Fusco, S., Peretti, G. M., Mangiavini, L., & Messina, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076405 · Cited by 387
Metadata
- Authors
- Wang, M., Yuan, Q., & Xie, L.
- Venue
- Stem Cells International
- Publisher
- Wiley
- Published
- 2018-06-14
- Volume
- 2018
- Pages
- 1-12
- ISSN
- 1687-966X (ISSN-L)
- 1687-9678
- OpenAlex
- W2808355836
- Cited by
- 505
- References
- 137
- FWCI
- 31.41
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.